Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery

Diabetes

Volumn 45, Issue 11, 1996, Pages 1610-1618

  Zaitsev, Sergei V ^a,b   Efanov, Alexandre M ^a,b   Efanova, Ioulia B ^a,b   Larsson, Olof ^a   Östenson, Claes Göran ^a   Gold, Gerald ^c   Berggren, Per Olof ^a   Efendić, Suad ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; INSULIN; PHENTOLAMINE; POTASSIUM CHANNEL; PROTEIN KINASE C; RX 871024; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CONDUCTANCE; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; EXOCYTOSIS; INSULIN RELEASE; MALE; MEMBRANE POTENTIAL; NONHUMAN; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 0029973985     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1610     Document Type: Article

References (46)

1. 2+ and pancreatic β-cell function. Biochem Soc Trans 22:12-18, 1994
2. Ashcroft SJH: Protein phosphorylation and beta-cell function. Diabetologia 37:S21-S29, 1994
3. Åmmälä C, Eliasson L, Bokvist K, Berggren PO, Honkanen RE, Sjöholm Å, Rorsman P: Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA 91:4343-4347, 1994
4. 2+ concentration and insulin secretion as evidenced from measurements in mouse single pancreatic islets. Proc Natl Acad Sci USA 92:9412-9416, 1995
5. Howell SL, Jones PM, Persuad SJ: Regulation of insulin secretion: role of second messengers. Diabetologia 37:S30-S35, 1994
6. Cerasi E, Efendić S, Luft R: Role of adrenergic receptors in glucose-induced insulin secretion in man. Lancet ii:301-302, 1969
7. Efendić S, Cerasi E, Luft R: Effect of blockade of the alpha-adrenergic receptors on insulin response to glucose infusion in prediabetic subjects. Acta Endocrinol 74:542-547, 1973
8. Efendić S, Cerasi E, Luft R: Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats. Diabetologia 11:407-410, 1975
9. Östenson CG, Pigon J, Doxey JC, Efendić S: Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. J Clin Endocrinol Metab 67:1054-1059, 1988
10. Östenson CG, Cattaneo AG, Doxey JC, Efendić S: Alpha-adrenoreceptors and insulin release from pancreatic islets of normal and diabetic rats. Am J Physiol 257:E439-E443, 1989
11. Schulz A, Hasselblatt A: An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:321-327, 1989
12. Schulz A, Hasselblatt A: Dual action of clonidine on insulin release: suppression, but stimulation when alpha 2-adrenoceptors are blocked. Naunyn-Schmiedeberg's Arch Pharmacol 340:712-714, 1989
13. 2-sites. Br J Pharmacol 112:1065-1070, 1994
14. + channels in mouse pancreatic β-cells. Br J Pharmacol 101:115-120, 1990
15. + channels in pancreatic beta-cells. Br J Pharmacol 107:8-14, 1992
16. ATP channels in insulin secreting cells. Eur J Pharmacol 204:41-18, 1991
17. Chan SLF, Morgan NG: Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur J Pharmacol 176:97-101, 1990
18. Chan SLF, Stillings MR, Morgan NG: Mechanisms involved in stimulation of insulin secretion by the hypoglycapmic alpha-adrenergic antagonist, DG-5128. Biochem Biophys Res Comm 176:1545-1551, 1991
19. Berridge TL, Doxey JC, Roach AG: Comparison of the affects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats. Eur J Pharmacol 213:213-218, 1992
20. Brown CA, Chan SLF, Stilling MR, Smith SA, Morgan NG: Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080. Br J Pharmacol 110:1017-1022, 1993
21. Östenson CG, Grill V: Differences in long-term effects of L-glutamine and D-glucose on insulin release from rat pancreatic islets. Mol Cell Endocrinol 45:215-221, 1986
22. 2+ in the pancreatic β-cell. FEBS Lett 303:85-90, 1992
23. Tsien RY, Rink TJ: Neutral carrier ion-selective microelectrodes for measurements of intracellular free calcium. Biochim Biophys Acta 599:623-638, 1980
24. 2+ influx in a clonal pancreatic beta-cell line (HIT T15). FEBS Lett 220:103-107, 1987
25. Corkey BE, Glennon MC, Chen RS, Deeney JT, Matschinsky FM, Prentki M: A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic β-cells. J Biol Chem 264:21608-21612, 1989
26. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391:85-100, 1981
27. Horn DR, Marty A: Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92:145-159, 1988
28. Parker RB, Waud DR: Pharmacological estimation of drug-receptor dissociation constants: statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1-12, 1971
29. Brown CA, Loweth AC, Smith SA, Morgan NG: Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites. Br J Pharmacol 108:312-317, 1993
30. 1-imidazoline agonist. Cardiovasc Drug Ther 8:27-41, 1994
31. Tibirica E, Feldman J, Mermet C, Gonon F, Bonsquet P: An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. J Pharmacol Exp Ther 256:606-613, 1991
32. Rorsman P, Ämmälä C, Berggren PO, Bokvist K, Larsson O: Cytoplasmic calcium transients due to single action potentials and voltage-clamp depolarizations in mouse pancreatic β-cells. EMBO J 8:2877-2884, 1992
33. + channels in mouse B cells. J Clin Invest 89:1288-1295, 1992
34. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm 159:548-553, 1980
35. Botelho LH, Webster LC, Rothermel JD, Baraniak J, Stec WJ: Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3′-,5′-phosphorodithioate, a second cAMP antagonist. J Biol Chem 263:5301-5305, 1988
36. Chijima T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromo- cytoma cells. J Biol Chem 265:5267-5272, 1990
37. Arkhammar P, Nilsson T, Welsh M, Welsh N, Berggren PO: Effects of protein kinase C activation on the regulation of the stimulus-secreting coupling in pancreatic β-cells. Biochem J 264:207-215, 1989
38. 2-receptors. Eur J Pharmacol 262:41-48, 1994
39. + channels in mouse pancreatic beta-cells. Br J Pharmacol 104:385-390, 1991
40. + channels in mouse pancreatic beta-cells by external tetraethylammonium and quinine. J Physiol 423:337-342, 1990
41. Persaud SJ, Jones PM, Howell SL: Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A. Biochem Biophys Res Comm 173:833-839, 1990
42. Malaisse WJ, Sener A: Inhibition by 1-(5-isoquinoline-sylfonyl)-2-methylpiperazine (H-7) of protein kinase C activity and insulin release in pancreatic islets. IRCS Med Sci 13:1239-1240, 1985
43. Hughes SJ, Ashcroft SJH: Effects of a phorbol ester and clomiphene on protein phosphorylation and insulin secretion in rat pancreatic islets. Biochem J 249:825-830, 1988
44. Kashiwagi A, Harono Y, Suzuki M, Kojima H, Harada M, Nishio Y, Shigeta Y: New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients. Diabetes 35:1085-1089, 1986
45. Kawazu S, Suzuki M, Negishi K, Watanabe T, Ishii J: Studies of midaglizole (DG-5128): a new type of oral hypoglycemic drug in healthy subject. Diabetes 36:216-220, 1987
46. Kawazu S, Suzuki M, Negishi K, Ishii J, Sando H, Katagiri H, Kanazawa Y, Yamanouchi S, Akanuma Y, Kajinuma H, Suzuki K, Watanabe K, Itoh T, Kobayashi T, Kosaka K: Initial phase II clinical studies on midaglizole (DG-5128): a new hypoglycemic agent. Diabetes 36:221-226, 1987